Previous 10 | Next 10 |
home / stock / jnj / jnj articles
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks...
On Wednesday, the FDA approved Epkinly (epcoritamab-bysp) as the first and only T-cell-engaging bispecific antibody administered subcutaneousl...
Sanofi SA (NASDAQ:SNY) is calling for initial bids for its $20 billion consumer health division. The French pharmaceutical giant is also considerin...
For Immediate Release Chicago, IL – June 21, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the ...
Gilead Sciences, Inc. (NASDAQ:GILD) witnessed a flurry of Wall Street speculation regarding its potential involvement in the obesity drug market. B...
Johnson & Johnson (NYSE:JNJ) is reportedly facing a new proposed class action lawsuit seeking damages and medical monitoring for women who have...
Thursday, Johnson & Johnson (NYSE:JNJ) released topline data from the pivotal Phase 3 GRAVITI investigational study of Tremfya (gusel...
Sunday, Nurix Therapeutics Inc (NASDAQ:NRIX) announced the presentation of updated clinical data for NX-5948, an orally bioavailable degrader of Br...
In today's fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct comprehensive compa...
News, Short Squeeze, Breakout and More Instantly...
2024-06-29 08:21:00 ET We have closed the books on a strong first half of the year for the U.S. stock market, something that a lot of people overlooked. Now we embark on the second half of the year, which could bring some challenges, though July historically is the market's best-performing ...
Nipocalimab pivotal Phase 3 trial demonstrates longest sustained disease control in FcRn class for broadest population of myasthenia gravis patients PR Newswire First-and-only FcRn blocker to demonstrate superiority in activities of daily living (MG-ADL a ) over pl...
2024-06-25 06:54:00 ET Investing comes in many flavors, so there isn't a right or wrong approach: You should do what's best for you. That applies even to dividend investing. For some, dividend investing means maximizing immediate income, even if it requires sacrificing some growth and long-...